Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 270
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in United States (Insulin Icodec)

Recruiting
  • Diabetes Mellitus, Type 2
  • Insulin Icodec
  • Palm Springs, California
  • +8 more
Apr 26, 2023

Aging, Diabetes, Type 2, PreDiabetes Trial in San Antonio (Semaglutide Injectable Product, Lifestyle Counseling)

Recruiting
  • Aging
  • +3 more
  • Semaglutide Injectable Product
  • Lifestyle Counseling
  • San Antonio, Texas
    UT Health San Antonio
Apr 3, 2023

NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2 Trial in Worldwide (IVA337, Placebo, Empagliflozin)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Diabetes Mellitus, Type 2
  • Homewood, Alabama
  • +40 more
Jan 23, 2023

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +393 more
Jan 17, 2023

Diabetes, Type 2, Chronic Kidney Disease Trial in Worldwide (Semaglutide, Placebo (Semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Chronic Kidney Disease
  • Tucson, Arizona
  • +33 more
Jan 17, 2023

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Placebo (semaglutide)
  • Birmingham, Alabama
  • +73 more
Jan 13, 2023

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo insulin icodec, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Guntersville, Alabama
  • +91 more
Nov 11, 2022

Diabetes, Type 2 Trial in San Antonio (Oral semaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • San Antonio, Texas
    Novo Nordisk Investigational Site
Nov 18, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +178 more
Nov 3, 2022

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Sep 12, 2022

Diabetes, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG) Trial in San Antonio (Dapagliflozin,

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Aug 29, 2022

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +82 more
Aug 23, 2022

Diabetes, Type 2 Trial in Worldwide (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Canagliflozin 100 mg
  • +2 more
  • Little Rock, Arkansas
  • +121 more
Aug 18, 2022

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Aug 5, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +105 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Lancaster, California
  • +104 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +107 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +241 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Little Rock, Arkansas
  • +228 more
Jul 11, 2022

Diabetes, Type 2 Trial in Worldwide (IcoSema, Insulin icodec)

Recruiting
  • Diabetes Mellitus, Type 2
  • Roswell, Georgia
  • +17 more
Jul 13, 2022

Diabetes, Type 2 Trial in United States (semaglutide, oral glucose-lowering medications (commercially available))

Recruiting
  • Diabetes Mellitus, Type 2
  • semaglutide
  • oral glucose-lowering medications (commercially available)
  • Alhambra, California
  • +23 more
Jul 8, 2022

Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Metformin DR
  • +3 more
  • Glendale, Arizona
  • +86 more
Jun 7, 2022

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Escondido, San Antonio, Renton (Continuous Glucose Monitoring System)

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Continuous Glucose Monitoring System
  • Escondido, California
  • +2 more
May 11, 2022

Diabetes, Type 2 Trial in San Antonio (Placebo, Exenatide, Dapagliflozin)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Placebo
  • +3 more
  • San Antonio, Texas
    University Health System Texas Diabetic Institute
Apr 28, 2022

Diabetes, Type 2 Trial in Anaheim, Miami, San Antonio (LY3493269, Dulaglutide, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +2 more
Apr 4, 2022